Quantum Biopharma Ltd (QNTM) 銘柄情報

QNTM: BEST of outcomes on your Post-M gambit there!!! (For me, what a FREAKISH turmoil at the end there!! I tried to DUMP all at the last 2-minute mark, but my E-Turd platform was failing miserably; so, I got stuck in the Post-M [E-Turd] routine, which also was screwing-up --- but I finally was able to DUMB all therein for a [shockingly] REASONABLE profit. This stock was NOT looking good all day long, and then it half-assed SOARED way near the end!! BONKERS stuff!!)

Grabbed some $6s hoping for a continuation tmrw looking good so far AH

QNTM: Impossible!!

QNTM: Maybe a TOM-BRADY-LIKE comeback, looming here shortly, Peeps??? Stranger things HAVE happened, ya know. (Meanwhile, see ME live right now below --- performing my OWN 'Investigational-Drug-Study' to see if QNTM's disruptive new "UnBuzzd" elixir really works!!!)

QNTM: Below is my inquiry of COPILOT about this Firm ---

MY QUESTION: "Does Wall Street think that QNTM's "UN-BUZZ" for alcohol is a joke?? Because people drink ALCOHOL to in fact GET "buzzed" and, as such, don't even WANT to get sober!!"

COPILOT: "It seems like there's some skepticism around Quantum BioPharma Ltd.'s (QNTM) product Unbuzzd, which aims to accelerate alcohol metabolism and reduce the effects of intoxication. While some people might indeed enjoy the feeling of getting "buzzed," there's also a market for those who want to sober up quickly, whether for safety reasons, to avoid hangovers, or to be more alert. The clinical trial results for Unbuzzd showed promising outcomes, such as accelerated alcohol metabolism, improved alertness, and reduced hangover symptoms. However, whether Wall Street views it as a joke or a viable product might vary among analysts and investors."

QNTM: Heck, beats flippin' BURGERS at Denny's!! (No puns intended.)

QNTM: Hopefully, a 'QUANTUM' leap in PRICE is looming here shortly, Homeboys!! (No puns intended.)

$7.72 halt 

Flip $5s for $6s $6.41

Since our last postings this has traded all the shares again and is up another 30 cents

Thanks for that update!

Shot was
https://sureshot.com/
Shot is 46-47 cent stock

Don’t know which is a better shot, but with QNTM only having less than 2 million shares and the whole thing being bought and sold 8 times already this morning, it is getting a lot of advertising.

Volume drives interest

QNTM: Don't know about that "SHOT" stuff, but GREAT news here; could be HUUUUUUUUGE market potential.

$6.46 I'll drink to that and then take some QNTM it's available online already... whatever happened to SHOT. This formula must be better then SHOT

QNTM: Tiny float, monster issues, epic news --- when have ya ever seen a stock PRESS RELEASE like this!!!
https://finance.yahoo.com/news/quantum-biopharma-announces-success-unbuzzd-120300003.html

QNTM: Might have a 5-bagger here, Homeboy!!

$6.08 +'90% ...Consumers now have the benefit of knowing that unbuzzd™ can reduce alcohol intoxication, speed the reduction of blood alcohol concentration, restore mental alertness and well-being, and help them avoid the worst symptoms of a hangover.”

Unbuzzed.. $6.99 + 120%

QNTM........................https://stockcharts.com/h-sc/ui?s=QNTM&p=W&b=5&g=0&id=p86431144783

https://x.com/harringtonkevin/status/1844015632146104631?s=46&t=KftAd6QFthE5qDXRLcppbA

QNTM.....................................https://stockcharts.com/h-sc/ui?s=QNTM&p=W&b=5&g=0&id=p86431144783

They've done this a few times in the past. Central question: how's the company being run? And how's the sciences development going? How is the trial going? Is it solid legit science with solid reputable scientists?

Voting control of the company secured for $36 bucks. Anthony and Zeeshan couple of shameless white collar thieves. HUGE insider scam using the company as their own personal ATM for years. https://www.stocktitan.net/news/QNTM/quantum-bio-pharma-closes-private-placement-fcqch3xznvm3.html

This is being run into the ground. Probably a further RS its an ATM just like the last RS

Don’t have a clue other than insider selling

Do you know why the gap down today?

Just weak chart and shorts? News?

QNTM new 52 week low

QNTM under $5

wow

Piggies lined up at the trough for another feeding oink oink oink. https://finance.yahoo.com/news/quantum-biopharma-announces-intention-complete-233000194.html

that was easy. blah blah bs

Garbage in, Garbage out

$3.7403 QNTM = $0.0575 HUGE. Why? Is this BKing?

QNTM new 52 week low

Instead of issuing general OTC style complaint, just back-up what you say with citations of the financials and actual numbers to actually make and support your case, as supported by cited facts.

Huge started tanking wayyyy before Cellynu was ever in the picture. You must be relatively new to Huge. They can try to whitewash all they want with a name change. Raza, Anthony, Saeed, all pigs at the trough pointing at and blaming one another all growing fat as retail starve. It's all there, ignore the hype and look at the facts. Over the years money has always gone into their pockets and promotions along with awarding themselves massive bonuses. If they truly intended to build true shareholder value more money would go into R&D instead of paid promotions and their pockets. Look at the amounts for paid promotions and salaries over the years then look at the total amount spent on R&D. They spend substantially more on promotions to hype and push paper than they do on R&D to actually build the company.

"on to their next venture..." You're saying all the biopharma research and hired scientist researchers, and Lucid, and Cellynu are all a stock play to move onto the the next venture?

That's easy. Standard bitter generalization without specifics to back up your claims. The financials you copy/pasted counter your claims.

The company capex is valued more than the current marketcap.

The previous 201 reverse was former CEO Bokouri (sp?), who now court ordered has to payback $3M to the company.

They dividended Celly Nutrition. Did you get your Cellynu shares?

Cellynu controversy is when HUGE (now QNTM) started to tank, very heavily shorted by hate crew opponents, likely helped in part by the scammers on the Safeshot equation side.

That they hired stock milker Edward DeFeudis and his pump marketing company is to me not a positive sign, and suggests stock scam players. Maybe they wanted to counter the short attack, but that recent volume suggests lots of naked shorting.

What are you reading in the financials that shows this company is a scam play?

Standard OTC bitter argument.

(overgeneralized, no specifics)

They have shares to push and dilute. Maybe they can RS two more times. Can you believe they went from 1.2 billion shares down to 7.7 million, back to 78 million, then down to 1.2 million? Pump, dilute, split and repeat, the cycle continues. If the company folded insiders risk nothing, walking away with millions from over the years and on to their next venture, can the same be said for the retail class B shareholders off of who's backs this company was built?

Insiders have milked this for years, it's a continual cycle of pigs taking turns often fighting over the trough getting their fill moving on then replaced with new piglets. Look at ALL company filings since their cannabis days, follow the money and who has come and gone over the years. The company financials and filings tell the true story of what has happened and is happening here. They have spent more on promotion and hype than on actual R&D, leadership is going to continue to hype and promote to convince naive shareholders that they are doing anything but paying themselves the money they stole from the investing public through secondary offerings. The rot runs deep.

OK, but the point, that the text from the Quarterly that you posted doesn't show anything abnormal or show a spendown in cash reserves. In fact, what you posted shows lower expenditures, except for $450K increase to Investor Relations.

What in the Quarterly and Annual filings (since 2018, as you state) are you referencing about that shows to support where the cash was spent specific to your claim: "Here is where the money goes."?

I agree $50M to $3M+ in cash is something. By itself not a reasonable reason the stock has tanked from recent $1.35 to current $0.06.

Feel free to look over the company filings and financials from 2018 to present.

Nothing abnormal here, except maybe some increase in costs to Investor Relations. Many decreases in costs you have posted here. Your post doesn't show where $47M of $50M of cash went.

i don't like that Investor Relations is newly serial OTC scammer Edward DeFeudis and his company.

Is the quiet word that all their scientists and researchers don't exist?

QNTM new 52 week low

Looks like alot of pigs taking turns eating out of the preverbal trough. This POS never stood a chance the way these bandits ran and I assume will continue to run it. Terribly managed.!!

At one point they had over 50mil in cash, dangling it like a carrot in their promotions targeting retail. Here is where the money goes: Current assets Cash and cash equivalents 3,306,641 June 30, 2024

Professional fees

Professional fees were $958,377 and $1,816,800 for the three and six months ended June 30, 2024, compared to $814,488 and $1,408,774, respectively, for the comparative periods in the prior year. This represents an increase of $143,889 or 18% for the three months ended June 30, 2024, and an increase of $408,026 or 29% for the six months ended June 30, 2024, compared to the equivalent periods in the prior year. Professional fees fluctuate from period to period based on the nature of the transactions the Company undertakes.

Investor relations

Investor relations expenses were $561,054 and $833,216 for the three and six months ended June 30, 2024, compared to $100,158 and $347,550, respectively, for the comparative periods in the prior year. This represents an increase of $460,896 or 460% for the three months ended June 30, 2024,and an increase of $485,666 or 140% for the six months ended June 30, 2024, compared to the equivalent periods in the prior year. Investor relations expenses fluctuate from period to period based on the Company’s business strategy.

Salaries, wages and benefits

Salaries, wages and benefits expenses were $436,687 and $816,139 for the three and six months ended June 30, 2024, compared to $465,899 and $1,095,926, respectively, for the comparative periods in the prior year. This represents a decrease of $29,212 or 6% for the three months ended June 30, 2024, and a decrease of $279,787 or 26% for the six months ended June 30, 2024,compared to the equivalent periods in the prior year. The decrease is primarily due to a decrease in headcount for the three months ended June 30, 2024, compared to the equivalent periods in the prior year. The decrease in headcount was due to a restructure in the research and development team and outsourcing of some related activities.

Consulting fees

Consulting fees were $204,492 and $423,453 for the three and six months ended June 30, 2024,compared to $269,067 and $825,871, respectively, for the comparative periods in the prior year. This represents a decrease of $64,575 or 24% for the three months ended June 30, 2024, and a decrease of $402,418 or 49% for the six months ended June 30, 2024,compared to the equivalent periods in the prior year. Consulting fees include fees paid to individuals and professional firms who provide advisory services to the Company and fluctuate from period to period based on the nature of the transactions the Company undertakes

Share-based payments

Share-based payments were $111,524 and $169,267 for the three and six months ended June 30, 2024,compared to $403,393 and $3,609,928, respectively, for the comparative periods in the prior year. This represents a decrease of $291,869 or 72% for the three months ended June 30, 2024, and a decrease of $3,440,661 or 95% for the six months ended June 30, 2024, compared to the equivalent periods in the prior year. Share-based payments expense changes based on the variability in the number of options granted, vesting periods of the options, the number of Performance Share Units (“PSUs”) granted, the number of Restricted Share Units (“RSUs”) granted, vesting periods of the PSUs and RSUs, number of warrants granted, vesting periods of the warrants, the grant date fair values of share-based awards, and share-based bonuses issued. The decrease for the period ended June 30, 2024, is primarily related fewer stock options grants in the current period compared to prior year period.

Office and general administrative

Office and general administrative expenses were $44,682 and $100,512 for the three and six months ended June 30, 2024, compared to $472,792 and $899,638, respectively, for the comparative periods in the prior year. This represents a decrease of $428,110 or 91% for the three months ended June 30, 2024,and a decrease of $799,126 or 89% for the six months ended June 30, 2024,compared to the equivalent periods in the prior year. Office and general administrative expenses may vary from period to period based on operational activities.


20. Subsequent Events

The Company issued three new loans secured by residential or commercial properties during July and August 2024 and renewed one existing loan in July 2024.

The total amount of these loans was equivalent to $1,866,370 (C$2,585,000).

The Company generated total proceeds of approximately $5,542,952 through its ATM Agreement subsequent to June 30, 2024. The proceeds will be used in the normal course of business operations.

The Company issued a total of 950,000 Class B shares to settle debts owing to an arm’s length creditor. Retail shredder, insider ATM machine.

It all started with the claims of Worlds Largest Hydroponics Cannabis Producer. They prey on retail through hype and promotion knowing most will not bother to check or understand company filings. The insiders use the company as their personal ATM. Shareholders have no say due to the share structure set up by insiders giving them full control with all voting matters. To explain it all would take pages of typing. But IMO this is a share dilution scheme meant to enrich insiders and a handful of other high net worth individuals.

What was the pump and dump scheme?

Current trading price pre-split is .06

Have to love these Canadians. No shame in their game!

HUGE to QNTM, Quantum Biopharma Ltd
Reverse split, 1:65